Investigates Morus alba leaf extract's effects on melanogenesis in cellular and zebrafish models, indicating pharmacological relevance.
Objective: To investigate the modulatory effects of a Morus alba leaf extract (FBCC-EP1619) on melanogenesis using enzymatic, cellular, and zebrafish models. Methods: Phytochemical profiling was conducted using UPLC-QTOF-MS/MS in negative ion mode. Mushroom tyrosinase inhibition was assessed in vitro. Cytotoxicity and melanin content were measured in B16F10 melanoma cells under basal and α-melanocyte-stimulating hormone (α-MSH-stimulated conditions. An in vivo pigmentation model was established using α-MSH-treated zebrafish larvae, and pigmentation was quantified. Expression of melanogenesis-related genes ( mitfa and tyr ) was analyzed by RT-qPCR. Results: FBCC-EP1619 contained diverse phenolic and lipid-derived metabolites. The extract significantly inhibited mushroom tyrosinase activity in a concentration-dependent manner. In B16F10 cells, it did not induce cytotoxicity but increased melanin production. In contrast, in α-MSH-stimulated zebrafish larvae, FBCC-EP1619 attenuated hyperpigmentation and significantly downregulated mitfa and tyr expression, indicating system- and stimulus-dependent regulation. Conclusions: FBCC-EP1619 differentially modulates melanogenesis depending on the biological system, enhancing basal melanin production in vitro while suppressing α-MSH-induced pigmentation in vivo. These findings provide pharmacological support for the ethnopharmacological relevance of Morus alba leaves and warrant further investigation into the underlying molecular mechanisms.
No takes yet. Share an insight, caveat, or question.
Kavinda et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: